Royce & Associates LP Lifevantage Corp Transaction History

Royce & Associates LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$12.07 - $15.31 $20,181 - $25,598	-1,672 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$10.25 - $16.54 $1,640 - $2,646	-160 Reduced 8.73%	1,672 $23,000
Q1 2020 May 12, 2020	BUY	$7.91 - $16.96 $1,574 - $3,375	199 Added 12.19%	1,832 $19,000
Q4 2019 Feb 06, 2020	SELL	$13.48 - $15.86 $5,782 - $6,803	-429 Reduced 20.81%	1,633 $25,000
Q3 2019 Nov 13, 2019	BUY	$10.8 - $14.6 $6,793 - $9,183	629 Added 43.89%	2,062 $28,000
Q2 2019 Aug 12, 2019	BUY	$10.68 - $14.55 $2,200 - $2,997	206 Added 16.79%	1,433 $19,000
Q1 2019 May 09, 2019	BUY	$12.54 - $16.12 $3,160 - $4,062	252 Added 25.85%	1,227 $18,000
Q4 2018 Feb 11, 2019	SELL	$10.06 - $14.87 $3,168 - $4,684	-315 Reduced 24.42%	975 $13,000
Q3 2018 Nov 13, 2018	BUY	$6.33 - $13.02 $8,165 - $16,795	1,290 New	1,290 $14,000
Q4 2017 Feb 09, 2018	SELL	$4.43 - $6.43 $6,131 - $8,899	-1,384 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$2.92 - $5.02 $4,041 - $6,947	1,384	1,384 $6,000

4.15M

34.9K

Ticker LFVN
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 12,560,000
Market Cap $194M
Description
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.